Prawo i regulacje · 26/08/2005

DEA Clarifies Requirements for Prescribing Schedule II Controlled Substances

The US Drug Enforcement Administration (DEA) has issued a clarification on the requirements for prescribing Schedule II controlled substances for pain treatment, following comments received on the subject in 2005.